Gilead Sciences, Inc. (Nasdaq: GILD) today announced additional data from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752) providing an overview of the efficacy and safety of twice-yearly lenacapavir ...
Barclays analyst Carter Gould maintained a Hold rating on Gilead Sciences (GILD – Research Report) on October 4 and set a price target of ...
The office market may have hit its bottom following a series of stressed property sales at discounted rates during the past ...
47mon MSN
Squarespace impresses with its advanced design options and user-friendly interface, while Hostinger shines with its ...
The move follows mandatory foundational GenAI training, which the firm says was completed by over 80% of its staff.
There are barriers preventing many Latino farm workers in northeastern Tennessee from trying to get help, but the extended ...
The Duchess of Sussex, who was at the event without her husband, revealed she was 'happy to be there to support' LA Children's Hospital at the gala yesterday evening. The 43-year-old, who ...
Quinne Rogers will join Hachette Book Group’s Grand Central Publishing imprint as VP and executive director of marketing on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback